Sichenzia Ross Ference Kesner LLP

Author Archives: Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters. Visit SRFK's LinkedIn page

Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corporation in a $4.75 Debt Transaction

new age beverage corp. logo

Press Release – New York, NY – June 20, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented New Age Beverages Corporation (“NASDAQ. NBEV”), a Colorado based organic and natural healthy beverage company in a $4.75 million senior secured convertible promissory note transaction. A portion of the proceeds were used to repay the Company’s line of credit with US Bank. The Company also converted debt held by Sunkist Growers, Inc. an agricultural marketing cooperative, into shares of its common stock.

The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Of Counsel, Kimberly Boler.

Partner Harvey Kesner Publishes Article on US Regulators’ Struggle to Address Cryptocurrencies, ICOs and STOs   

Press Release – New York, NY – June 22, 2018 Sichenzia Ross Ference Kesner LLP name partner Harvey Kesner published an article titled NASDAQ’s Blockchain Experiment Shows How Foreign Markets will Continue to Lead While US Regulators Catch Up” in Law360.  Mr. Kesner noted that in his opinion the failure of US agencies such as the SEC and Nasdaq to develop clear guidelines for the new blockchain industry will allow foreign jurisdictions to attract issuers while development in the US will be stifled.  Read the full article here: NASDAQ’s Blockchain Experiment Shows How Foreign Markets will Continue to Lead While US Regulators Catch Up

Sichenzia Ross Ference Kesner LLP Represents ThinkEquity, a Division of Fordham Financial Management as Sole Book-Running Manager on $18 Million Public Offering of Securities of Trovagene, Inc.

trovagene logo

Press Release – New York, NY – June 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager on its first underwritten public offering since launching its new ThinkEquity division.

continue reading >>

33/34 Act, M & A Corporate Associate

We are seeking a corporate associate with 3-5 years of experience in the field of securities and corporate law. This is an excellent opportunity for skilled candidates looking to work in a nationally recognized regional securities practice located in midtown Manhattan.  Experience and knowledge with registered securities offerings, PIPEs, SEC regulations, ’33 Act Registration Statements, ’34 Act periodic filings, mergers & acquisitions, general corporate law and SEC research. To apply, please contact: mzavala@srfkllp.com and tbarone@srfkllp.com

Partner Marc J. Ross Presents Webinar on Cannabis, “Weeding Out the Confusion In Marijuana Law”

New York, NY – June 7, 2018 – Partner Marc Ross will be presenting a webinar course at the Clear Law Institute, “Weeding Out the Confusion In Marijuana Law”, on Thursday, June 7, 2018. This presentation, which is Continuing Legal Education (“CLE”) accredited, will discuss the conflicts between state and federal law and their impact upon the marijuana industry, generally as well as the banking, tax and various other issues facing the growing marijuana industry, specifically.

More information about the webinar is available here.

Junior Real Estate Associate

We have an immediate need for a junior associate attorney, with 0-2 years’ experience, for our growing real estate practice.  The ideal candidate will have experience in aspects of both commercial and residential real estate, including: document preparation, closings, real estate financing and commercial leasing.  In addition, the candidate should be well organized, have strong writing skills and be a self-starter.  This is a position for someone who wants to learn, gain experience, and grow as a real estate transactional attorney.  To apply, please contact mzavala@srfkllp.com.

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.1 Million Registered Direct Offering

pareteum logo

New York, NY – May 14, 2018 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it represented Pareteum Corporation (NYSE: TEUM), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering of 2,440,000 shares of common stock. The purchase price per share was $2.50. Pareteum received gross proceeds of $6.1 million.

continue reading >>

Partner Harvey Kesner Publishes Article on SEC and Cryptocurrency in Law360

Press Release – New York, NY – May 8, 2018 Sichenzia Ross Ference Kesner LLP name partner Harvey Kesner published an article titled SEC Needs To Better Understand Cryptocurrency Industry” in Law360.  Mr. Kesner noted that in his opinion the SEC’s regulatory regime has not yet caught up with the evolving blockchain businesses.  Read the full article here.

 

Sichenzia Ross Ference Kesner LLP Represents Acolyte Group in the Sale of its LED Lighting Business to CapStreet Private Equity Group

acolyte group

May 2, 2018 — New York, NY.  Sichenzia Ross Ference Kesner LLP (“SRFK”) represented The Acolyte Group, a New York based provider of fully integrated LED lighting systems, in the sale of its entire business to General LED, a portfolio company of Houston, Texas based private equity firm Cap Street Group.

The SRFK team was led by Partners Thomas Rose and Gregory Sichenzia and Counsel Jeff Cahlon with assistance from Counsel Todd Manister from the SRFK Real Estate Group.

Sichenzia Ross Ference Kesner LLP Represents A.G.P/ Alliance Global Partners (through Euro Pacific Capital) in $8 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

cocrystal pharma

Press Release – New York, NY – May 3rd, 2018 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P./Alliance Global Partners, offering securities through Euro Pacific Capital, in an underwritten public offering of shares of common stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of common stock at a price of $1.90 per share. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.  The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.

Sichenzia Ross Ference Kesner LLP Represents Sunworks, Inc., in a $3.75 Million Debt Transaction

sunworks solar power

Press Release – New York, NY – April 27, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented Sunworks, Inc. (NASDAQ: SUNW), a premier provider of high performance solar power systems, in a $3.75 million two year term loan transaction. The lender is CrowdOut Capital LLC. Management, including the Chief Financial Officer, also participated in $750,000 of the loan amount.

The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and Marcelle Balcombe.

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP Represents PolarityTE, Inc., in $37.4 Million Public Offering

polarity te logo

Press Release – New York, NY – April 16, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented PolarityTE, Inc. (NASDAQ: COOL) in a $37.4 million public offering of common stock. A total of 2,335,937 shares of common stock were sold at a price of $16.00 per share, which includes shares sold upon exercise of the underwriters’ over-allotment option. Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corp. in $4 Million Underwritten Public Offering

new age beverage corp. logo

Press Release – New York, NY – April 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented New Age Beverages Corp.  (NASDAQ: NBEV) in a public offering of 2,285,715 shares of its common stock at a price of $1.75 per share for gross proceeds to NBEV of $4,000,000. A.G.P/ Alliance Global Partners  (Euro Pacific Capital) and Maxim Group L.L.C. acted as the Joint Book Running Managers for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a Unit of H.C Wainwright, in a  $10.5 Million Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – April 11, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (NASDAQ: MTBC).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents AYTU Bioscience, Inc., in $12 Million Public Offering

aytu bioscience

Press Release – New York, NY – March 6, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented AYTU Bioscience, Inc. (NASDAQ: AYTU) in a $12 million public offering of Class A Units, comprising common stock and warrants and Class B Units comprising Series B Preferred Stock and Warrants. A total of 19,520,000 Class A Units were sold at a price of $0.45 per unit and 3,216 Class B Units were sold at a price of $1,000 per unit.  The warrants are exercisable at a price of $0.54 per share for a term of 5 years. Joseph Gunnar & Co. acted as the Sole Book Running Managing Underwriter and Fordham Financial Management, Inc. acted as the Lead Managing Underwriter.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $5 Million Private Placement

moneyonmobile-logo

Press Release – New York, NY – February 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors in which MOMT received $4,998,000 in consideration for the issuance of 1,666 shares of Series H Preferred Stock and a five year warrant to purchase 3,332,000 shares of common stock at an exercise price of $0.50 per share.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in $7.6 Million of Private Placements

moneyonmobile-logo

Press Release – New York, NY – February 8, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors where MOMT sold an aggregate of 5,567 shares of Series F Preferred Stock.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Roth Capital Partners and Brookline Securities in a $5.5 Million Public Offering of QBIO Med.

QBioMed

Press Release – New York, NY – February 1, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Roth Capital Partners LLC as lead Placement Agent and CIM/Brookline Securities, as Co-Lead Placement Agent in a public offering of Common Stock and Warrants Series for QBIO Med, Inc. (OTC.QBIO). QBIO is a biotechnology acceleration and development company focused on acquiring and in-licensing life science therapeutics products.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $30 Million Above-Market Registered Direct Offering

vuzix view the future logo

Press Release – New York, NY – January 26, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 3,000,000 million registered shares of its common stock at a price of $10.00 per share and 1,200,000 1 year common stock purchase warrants with an exercise price of $10.00 per share  for gross proceeds to Vuzix of $30,000,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon. continue reading >>

Sichenzia Ross Ference Kesner LLP represents Teamtronics, Inc. in acquisition of High-Tech Solutions, Inc.’s Automotive Pattern Recognition Business

Press Release – New York, NY – January 25, 2018 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Teamtronics, Inc., a manufacturer of portable, rugged computerized equipment for industrial and field automation in its acquisition of High-Tech Solutions’ Automotive Pattern Recognition (“HTS-APR”) business. The acquisition includes all applicable assets including the intellectual property and customer base. The purchase price was approximately $4.0 million.

continue reading >>

Sichenzia Ross Ference Kesner LLP Congratulates Novume Solutions, Inc., on Nasdaq Uplisting

novume solutions inc.

Press Release – New York, NY – January 12, 2018 –  Sichenzia Ross Ference Kesner LLP announced today that the Firm represented Novume Solutions, Inc. (NASDAQ: NVMM), a leading provider of support services to the government contracting market, in the Company’s up-listing to the Nasdaq Capital Market. The Sichenzia Ross Ference Kesner LLP team was led by Partners Tom Rose and Marcelle Balcombe. The up-listing was effective for trading on January 10, 2018 and Novume’s common stock will trade under its existing stock symbol “NVMM.”

continue reading >>

The new deduction for qualified businesses: gobbledygook on steroids

Using some of the worst gobbledygook* we have seen in a while, Congress in the 2017 tax reform act has provided a tax break for some business owners, starting in 2018. It comes in the form of a deduction equal to a portion of your business profits, with limits. You can claim the deduction whether or not you itemize deductions. Here is a 10,000-foot view of the legislation, intended primarily to enable you to determine whether you need to deal with this puppy in the first place.

continue reading >>

Under new tax law, sales by foreign partners of U.S. partnership interests are once again taxable.

In an August 2017 posting we reported that the U.S. Tax Court had held that, notwithstanding an IRS revenue ruling to the contrary, the sale by a foreign partner of his interest in a U.S. partnership was not a taxable transaction to him (assuming he was not otherwise a U.S. taxpayer), just as the sale of stock in a U.S. corporation is not a taxable transaction to a foreign shareholder. (“Tax Court: Foreign investors not taxable on sales/liquidations, of U.S. partnership interests.”)

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Biotricity Inc. in $2.5 Million Registered Direct Offering

biotricity logo

Press Release – New York, NY – December 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Biotricity Inc. (OTCQB:BTCY”) in a Registered Direct public offering of 450,164 registered shares of its common stock at a price of $5.50 per share for aggregate proceeds of approximately $2.5 million.

The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $12.5 Million Registered Direct Offering

vuzix

Press Release – New York, NY – December 18, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2,066,116 million registered shares of its common stock at a price of $6.05 per share and 1,033,058 3-year common stock purchase warrants with an exercise price of $7.00 per share  for gross proceeds to Vuzix of $12,500,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a unit of H.C Wainwright, in a $3.9 Million Public Offering of Medical Transcript Billing, Corp.

mtbc - medical transcription billing corp. logo

Press Release – New York, NY – December 11, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.58 Million Registered Direct Offering and Concurrent Private Placement

pareteum logo

Press Release – New York, NY – December 6, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering and private placement offering of 7,151,146 shares of common stock and restricted five-year warrants to purchase up to 7,151,146 shares of common stock exercisable at $1.09 per warrant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents CloudCommerce, Inc., in Acquisition of WebTegrity, LLC

Press Release – New York, NY – November 17, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented CloudCommerce, Inc., a global provider of cloud-driven e-commerce and mobile commerce solutions, in its acquisition of WebTegrity, LLC (“WebTegrity”), a provider of enterprise digital marketing services based in San Antonio, Texas, through a merger with and into Parscale Digital, Inc., a wholly owned subsidiary of CloudCommerce, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MabVax Therapeutics Holdings, Inc. in $5 Million Registered Direct Offerings

mabvax therapeutics

Press Release – New York, NY – November 15, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, in a series of registered direct offerings of  common stock and preferred stock for aggregate gross proceeds of approximately $5,000,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $1.4 Million Registered Direct Offering

onconova logo

Press Release – New York, NY – November 14, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole placement agent in the registered direct offering of common stock securities of Onconova Therapeutics, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $12.0 Million Firm Commitment Public Offering

pareteum logo

Press Release – New York, NY – November 9, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a firm commitment underwritten offering of 9,009,478 shares of common stock, 4,034 shares of preferred stock (each of which shares is an equivalent of 920 shares of common stock), and five-year warrants to purchase up to 7,478,228 shares of common stock exercisable at $1.05 per warrant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Congratulates AYTU Biosciences, Inc., on NASDAQ Uplisting

aytu bioscience

Press Release – New York, NY – October 19, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that the Firm represented AYTU Biosciences, Inc. (NASDAQ: AYTU), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Partner Marcelle Balcombe. The up-listing is effective for trading on October 20, 2017 and AYTU’s common stock will trade under its existing stock symbol “AYTU.”

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc.

Press Release – New York, NY – October 18, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as Lead Placement Agent and Fordham Financial Management Co-Placement Agent  in a $6.75 million Registered Direct Public Offering of Common Stock of Ampio Pharmaceuticals, Inc. (“NYSE.AMPE”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $1.56 Million Shelf Take Down

pareteum logo

Press Release – New York, NY – October 12, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Pareteum Corporation (“Pareteum”), a rapidly growing mobile Cloud Communications Platform company, in connection with its shelf take down of 1,495,000 shares of its common stock. Gross proceeds to Pareteum from this offering are $1,569,750 before deducting placement agent’s commissions and other expenses.  Dawson James Securities acted as placement agent for the offering.

The Sichenzia Ross Ference Kesner LLP team was led by Partner Darrin M. Ocasio, Counselors Jeffrey Cahlon, and Cheryll J. Calaguio and Associate Evan Berger.

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP Cited as Top-Ranked Legal Counsel for PIPE Issuers in the Third Quarter 2017

Press Release — October 3, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP was recently cited as the top-ranked issuer legal counsel with eight PIPE placements advised in the third quarter 2017, according to The Deal.  The Deal’s exclusive League Table ranking tracks PIPEs that raise at least $1 million between January 1 and September 15, 2017. To read the press release, please click here.

Sichenzia Ross Ference Kesner LLP Represents JetSmarter Inc. in a Preferred Stock Rights Offering

jetsmarter_logo

Press Release — October 2, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP represented JetSmarter Inc., an innovative technology company and market leader in the premium private-flight-sharing economy, in a Rights Offering of its Series C-1 Preferred Stock.  The Rights Offering was anchored by the conversion of previous institutional investments made by lead sponsor, Clearlake Capital Group, L.P.

The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose and James Turner and Associates Jay Yamamoto and Will Rao.

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $6.0 Million Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – September 28, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Kesner LLP Real Estate Group Represents One Wall Partners in a $63 Million, 16-Building, Portfolio Acquisition

one wall partners

Press Release – New York, NY – September 20, 2017 – The real estate practice group of SRFK announced today that it recently closed on a $63 million, 16 building, multi-family, portfolio acquisition for One Wall Partners.  One Wall Partners is a vertically integrated real estate investment firm that specializes in the acquisition, development and management of transit-oriented workforce housing.  The Sichenzia Ross Ference Kesner LLP team was led by partner Anthony Ficara, counsel Michael Wickersham and associate Laura Kim.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co., LLC in $10 Million Public Offering of American Depository Shares of BiondVax Pharmaceuticals Ltd. (Israel)

biondvax pharmaceuticals

Press Release – New York, NY – September 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC. as sole book running manager in the underwritten public offering of American Depository Shares (ADS’s) of BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV, TASE BVXV), a clinical stage biopharmaceutical company focused on developing a universal flu vaccine. The public offering consisted of 1,500,000 ADS’s and the full overallotment of 166,667 additional ADS’s at a public offering price of $6.00 per ADS for gross proceeds of $10 million.  The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeffrey Cahlon and Associate Evan Berger.

Los Angeles Times Interviews Gregory Sichenzia on Google’s Potential Investment in Lyft

Press Release – New York, NY – September 17, 2017 – Founding Partner Gregory Sichenzia spoke with the Los Angeles Times’ technology reporter Tracey Lien to discuss the impact of a potential investment in Lyft by Google, as the technology giant already has a size-able investment in Uber, another ride sharing company. Sichenzia was quoted numerous times throughout the article, which can be found here.

Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. in $6 Million Public Offering of Units of Precipio, Inc.

precipio diagnostics

Press Release – New York, NY – August 23rd, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of Units of Precipio, Inc. (NASDAQ: PRPO). Each Unit is comprised of 1 share of Series B Preferred Stock which is convertible into 400 shares of common stock at a price of $2.50 per share and one warrant to purchase 400 shares of common stock at $3.00 per share.   Precipio provides diagnostic information to physicians and there patients worldwide.  The Sichenzia Ross Ference Kesner LLP team was led by partner Tom Rose and counsel Jeff Cahlon.

Rodman & Renshaw Conference in NY, NY on September 10-12, 2017

Sichenzia Ross Ference Kesner LLP is a silver sponsor of the 19th Annual Rodman & Renshaw Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 10 to September 12. A memorable and exciting conference is anticipated with over 300 public and private companies presenting their businesses to an audience of approximately 2,000 attendees.

September 10 – 12, 2017
New York City
Lotte New York Palace Hotel
455 Madison Avenue at 50th Street
New York, NY 10022

Visit Here to learn more

Sichenzia Ross Ference Kesner LLP Relocates NYC Headquarters

Sichenzia Ross Ference Kesner LLP is pleased to announce that as of August 25, 2017 we have moved to a new location at 1185 Avenue of the Americas, 37th Floor, New York, NY 10036.

As we enter our 20th year as a leading corporate, securities and litigation law firm, and expand our practice areas to include real estate and trusts and estates, our move to this vibrant mid-town New York City location will help us to better serve our diverse client base in New York and around the world.

This new location provides our many colleagues and clients with facilitated ease of travel in and out of the city. We will share photos of the new office space as soon as we have them. Please feel free to contact marketing@srfkllp.com with any questions — we hope to see you soon in our new home!

Partner Benjamin Tan Joins China Internet Nationwide Financial Services, Inc. in Ringing the Closing Bell at Nasdaq MarketSite

Press Release – New York, NY – August 16, 2017 – Sichenzia Ross Ference Kesner LLP partner,  Benjamin Tan joined China Internet Nationwide Financial Services, Inc. (NASDAQ: CIFS) , a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in ringing the closing bell at Nasdaq MarketSite in Times Square on August 15, 2017. CIFS recently closed on an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share on July 31, 2017  and its shares currently trade on the NASDAQ Global Market.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as lead placement agent and Fordham Financial Management, Inc. co-placement agent  in a private placement offering of equity securities of Aytu BioScience, Inc.  (OTC Market “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $8.6 Million Registered Direct Offering

vuzix view the future logo

Press Release – New York, NY – August 14, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 1.5 million registered shares of its common stock at a price of $5.75 per share  for gross proceeds to Vuzix of $8,625,000.Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP Represents JetSmarter Inc. in Institutional Investment from Clearlake Capital Group and Leucadia National Corporation

jetsmarter_logo

Press Release — August 10, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP represented JetSmarter Inc., an innovative technology company and market leader in the premium private-flight-sharing economy, in an institutional capital raise.  The investment was anchored by lead sponsor, Clearlake Capital Group, L.P. and included participation from Leucadia National Corporation and existing investors.  Jefferies LLC acted as the exclusive placement agent to JetSmarter Inc. in connection with the financing.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents CloudCommerce, Inc., in Acquisition of Parscale Creative, Inc.

cloudcommerce inc

Press Release – New York, NY – August 2, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented CloudCommerce, Inc., a global provider of cloud-driven e-commerce and mobile commerce solutions, in its acquisition of Parscale Creative, Inc., a company engaged in the digital marketing business, through a forward triangular merger with Parscale Digital, Inc., a newly formed wholly owned subsidiary of CloudCommerce, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in Registered Direct Offering

medovex corporation

Press Release — New York, NY — August 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a registered direct offering of units consisting of 2,956,046 shares of common stock and 1,478,023 warrants to purchase common stock at a price of $0.91 per unit resulting in gross proceeds of $2,680,000.

The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Arthur Marcus. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents China Internet Nationwide Financial Services Inc. on $20 Million Public Offering

china internet nationwide financial services

Press Release – New York, NY – July 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS), a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 8, 2017 under the symbol “CIFS.”

continue reading >>

Sichenzia Ross Ference Kesner’s Jodi Zimmerman Conducts Q&A on “What You Should Know About Creating A Last Will & Testament”

Press Release – New York, NY – July 26, 2017 – Jodi B. Zimmerman, Esq. of Sichenzia Ross Ference Kesner LLP participated in a Q&A blog post hosted by eSignatureGuarantee Group, to share “What You Should Know About Creating A Last Will & Testament.” The Q&A outlines the reasons for planning ahead, what to be aware of, and most importantly — the impact on your family and community.

Read the entire post here.

Partner Harvey Kesner Rings Nasdaq Opening Bell with Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd.

Press Release – New York, NY – June 28, 2017 – Sichenzia Ross Ference Kesner LLP partner Harvey Kesner joined representatives of Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd., at the Nasdaq MarketSite in Times Square to ring the June 28, 2017 opening bell.

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs. The company’s American Depository Shares (ADSs) have traded on The Nasdaq Capital Market under the symbol “TRPX” since March 22, 2017.

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $7.4 Million Public Offering of Medical Transcript Billing, Corp.

mtbc - medical transcription billing corp. logo

Press Release – New York, NY – June 23, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcription Billing, Corp. (MTBC.NASDAQ). MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing

immuron

Press Release — New York, NY — June 14, 2017 — Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the Firm has represented Immuron Limited (NASDAQ: IMRN) (ASX : IMC), a clinical-stage biopharmaceutical company focused on NASH and OTC products, on the company’s U.S. underwritten public offering of American Depository Shares (ADSs) and warrants to purchase the company’s ADSs at a combined offering price of $10.00.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc.

ampio pharmaceuticals

Press Release – New York, NY – June 8, 2017 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it has represented Joseph Gunnar & Co. as Lead Placement agent and Fordham Financial Management as Co-Placement Agent  in a $6.6 million Registered Direct public offering of equity securities of Ampio Pharmaceuticals, Inc.(“NYSE MKT.AMPE”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Announces the Addition of an Established Commercial Real Estate Practice Group and Trust & Estates Practice Area

Press Release – New York, NY – June 7, 2017 – Sichenzia Ross Ference Kesner LLP (SRFK), a leading corporate securities and full service law firm, is pleased to announce the addition of a Commercial Real Estate group and Trusts & Estates practice to its growing number of practice areas.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MabVax Therapeutics Holdings, Inc. on $4.1 Million Public Offering

mabvax therapeutics

Press Release – New York, NY – June 5, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage oncology drug development company, in a public offering of common stock and Series G Preferred Stock for a total of $4.1 million. continue reading >>

Sichenzia Ross Ference Kesner LLP Advises Dataram Corporation on the Acquisition of U.S. Gold Corp.

Press Release – New York, NY – May 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented Dataram Corporation (NASDAQ: DRAM), a manufacturer of memory products and provider of performance solutions, in its acquisition of U.S. Gold Corp., an exploration stage mining company. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co. and Brookline Capital Markets in a $13.25 PIPE for MRI Interventions, Inc.

mri interventions

Press Release – New York, NY – May 26, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC, as lead Placement Agent and Brookline Capital Markets, a division of CIM Securities, LLC, as co-Placement Agent in a $13.25 Million PIPE transaction for MRI Interventions, Inc. (OTCQB: MRIC) a medical device company that is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain.

continue reading >>

Sichenzia Ross Ference Kesner LLP Attorneys Marc Ross and Mendy Piekarski Achieve Complete Dismissal of Shareholder Derivative Lawsuit

Press Release – New York, NY – May 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP recently achieved a complete dismissal of a shareholder derivative lawsuit. The shareholder plaintiff filed the derivative lawsuit in Arizona state court, asserting claims against former and current directors and officers of a company that had issued a restatement of its financial statements.

continue reading >>

Sichenzia Ross Ference Kesner Associate Cass Sanford Quoted in Business Insider Article on Topics Surrounding Reg A+

Press Release – New York, NY – May 12, 2017 – Sichenzia Ross Ference Kesner LLP associate Cass Sanford was recently quoted in a Business Insider article, sharing her insight surrounding Regulation A+ investment offerings, and why the JOBS Act mechanism for raising capital should still be considered in its infancy.

continue reading >>

Sichenzia Ross Ference Kesner LLP Advises PolarityTE, Inc. on Acquisition of Intellectual Property Related to Regenerative Medicine

Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented PolarityTE, Inc. (NASDAQ: COOL), a company which has developed and distributed software through online platforms and is also engaged in regenerative medicine, in its acquisition of intellectual property related to a novel regenerative medicine and tissue engineering platform developed by Dr. Denver Lough, the Company’s current Chief Executive Officer. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $5.2 Million Public Offering

onconova logo

Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). In connection with the offering, Onconova received approximately $5.2 million in gross proceeds from common stock sold at a price to the public of $2.10 per share.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cooltech Holding Corp. in a Private Placement of $2.9 Million in Common Stock

cool tech logo

Press Release – New York, NY – May 1, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Cooltech Holding Corp. (“Cooltech”), a consumer electronics, mobility and accessories distribution and marketing company, in connection with its sale of $2,859,000 of common stock to accredited investors. Cooltech sold 1,143,600 shares of common stock at a purchase price of $2.50 per share, pursuant to a private placement memorandum and related securities purchase agreement. Laidlaw & Company (UK) Ltd. acted as the placement agent for the private placement.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Marathon Patent Group, Inc. in $2.66 Million Registered Direct Offering

marathon patent group

Press Release – New York, NY – April 24, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Marathon Patent Group, Inc. (Nasdaq: Mara), an IP licensing and commercialization company, in a registered direct public offering of 3,800,000 registered shares of its common stock and 2,280,000 warrants at a price of $0.70 per share for gross proceeds of approximately $2,660,000.
continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for $2.1 Million Private Placement

protea biosciences

Press Release – New York, NY – April 17, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that between November 2016 and March 2017 it represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Protea Biosciences Group, Inc. (OTCQB: PRGB), a molecular information company that has developed a technology which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.

continue reading >>

Ronen Kantor

ronen kantor - Securities Law Firm | Sichenzia Ross Ference Kesner LLP

Managing Partner at DTKGC-SRFK*

Introduction

Ronen Kantor, Adv. is the founder of Kantor and Co. - Law offices and a managing partner of DTKGC . Mr. Kantor heads all the Corporate Finance Activities at DTKGC and is involved in most of the corporate transactions being managed by the firm. Mr. Kantor founded Kantor & co. Law Offices in 2000 with the goal of serving an increasing number of Israeli and foreign clients in various Corporate Finance activities both in Israel and internationally.

Mr. Kantor counsels public and private companies in securities matters in Israel, the US and the UK, and also in complex Merger and Acquisition transactions. Mr. Kantor's primary focus is corporate finance and securities laws, biotechnology and biopharmaceutical transactions, venture capital investments, private equity financings, mergers and acquisitions, general corporate law and other related activities.


*Ronen Kantor is a member of DTKGC-SRFK. This website is the website of the law firm Sichenzia Ross Ference Kesner LLP, a limited liability partnership doing business in New York and New Jersey. Services in Israel are provided through SRFK-DTKGC, a law firm organized under the laws of Israel that conducts business in Ramat Gan and Haifa in Israel. Sichenzia Ross Ference Kesner LLP and DTKGC-SRFK are each separate and independently owned firms. The Firms are parties to an affiliation agreement and operate under the global brands “Sichenzia Ross Ference Kesner LLP”, “SRFK LLP” and “DTKGC-SRFK”.

Professionals | Ronen Kantor | Sichenzia Ross Friedman Ference LLP

Education

University of Sheffield, England (LL.E. Honors, 1993)

Bar Admissions

Israeli Bar Association

Practice Areas

Corporate Law Group

Israeli Securities Law Group

Securities Law Group (U.S. and UK)

Israel practice group

Mergers and Acquisitions

Venture Capital & Investments

Private Equity Financings

Biotechnology & Licensing

International Transactions​

Contact Address

Office: Ramat Gan, Israel 5250606

Phone: +972-3-6133371

Fax: +972-3-6133372

Email: rkantor@dtkgc.com

Download vCard

Robert Volynsky

Associate

Introduction

Robert Volynsky is an associate in the firm’s Litigation Department. Mr. Volynsky engages in securities and general commercial litigation in both state and federal courts and before regulatory agencies, including the Securities and Exchange Commission and the Financial Industry Regulatory Authority. Prior to joining the firm, Mr. Volynsky interned as an Enforcement Intern in the Real Estate Finance Bureau at the New York State Attorney General’s office.

Education

Hofstra University School of Law, J. D. Honors Concentration in Business Law; Vice President, Dispute Resolution Society

University of California, Los Angeles, B.A.​

Bar Admissions

Robert is admitted to practice in California, New York, and New Jersey.

Practice Areas

Business Litigation & Arbitration

Contact Address

Office: New York

Phone: (212)-930-9700

Fax: (212)-930-9725

Email: rvolynsky@srfkllp.com

Download vCard

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down

tonix pharmaceuticals

Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Investor in a Private Placement of up to $5,000,000 in Series B Preferred Stock of Digital Power Corporation

Press Release – New York, NY – March 29, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Philou Ventures, LLC (“Philou”) in connection with its entry into a Preferred Stock Purchase Agreement (the “Purchase Agreement”) with Digital Power Corporation, a California corporation (the “Company”), a solution-driven organization that designs, develops, manufactures and sells high-grade customized and flexible power system solutions for applications in the medical, military, telecom and industrial markets.  The Purchase Agreement was executed on March 9, 2017.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Featured in Article Discussing Uptick in Coal and Gas IPOs

Press Release – New York, NY– March 28, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Law360 about the return of coal and gas issuers to the initial public offering landscape after a long absence. Greg attributed the boost partly to a change in administration, as investors expect a friendlier regulatory environment under the Trump administration. The article, titled “Coal Cos. Are Forging A Return To The IPO Pipeline,” is available here.

Sichenzia Ross Ference Kesner LLP Advises Laidlaw & Co. (UK) Ltd. on U.S. Public Offering and NASDAQ Listing of Israeli Cannabinoid Research Company Therapix Biosciences, Ltd. (TRPX)

therapix biosciences logo

Press Release – March 27, 2017 – New York, NY – Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the successful completion of a U.S. underwritten public offering of American Depositary Shares by Therapix Biosciences Ltd. (“Therapix”) an Israeli public company.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd., in a $2.8 Million Private Placement of ADSs.

xtlbio logo

Press Release – New York, NY – March 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals Ltd.  (“XTLB. NASDAQ”), an Israeli biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of lupus and other autoimmune diseases, in a private placement offering with existing investors where XTLB issued 1,400,000 American Depository Shares (ADSs) at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.

innovus pharma

Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $3.5 Million Public Offering

pareteum logo

Press Release – New York, NY – March 20, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSEMKT: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in an underwritten public offering of 2,333,334 shares of common stock at a public offering price of $1.50 per share together with the issuance of 1,166,667 five year warrants to purchase common stock with an exercise price of $1.87.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Discusses Shareholder Comments that Impact Stock Price

Press Release – New York, NY– March 13, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Business Insider about comments on Pandora stock by Liberty Media CEO Greg Maffei.  The article, titled “This media mogul has wreaked havoc on Pandora’s stock price for months — and he’s not slowing down,” discusses recent positive and negative comments by Mr. Maffei about Pandora. Greg addressed the legality of public statements that can impact stock price. 

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.

Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Featured in CNBC Story on Investing in Start-ups

Press Release – New York, NY – March 3, 2017 – Founding Partner Gregory Sichenzia was recently featured in a CNBC article authored by Kayleigh Kulp. The article entitled, “New Horizons: How to Invest in a Startup,” reviews the many things investors must know to effectively evaluate and invest in a start up.

continue reading >>

Mixiii BioMed 2017 Conference

Representatives of Sichenzia Ross Ference Kesner LLP and our affiliates, Doron, Tikotzky, Kantor, Gutman, Cederboum and Co., will be attending Biomed’s 16th National Life Science & Technology Conference, to be held at the David Intercontinental in Tel-Aviv, Israel on May 23rd – May 25th, 2017. Biomed has positioned itself throughout the years as the main annual meeting place for players of Israel’s healthcare industry with their colleagues from around the globe. It presents a unique and exuberating occasion for participating in discussions, panel presentations, product demonstrations and networking opportunities, all paving the way for new business collaborations.

May 23rd – May 25th, 2017
Tel-Aviv, Israel

David Intercontinental Hotel
Kaufmann St 12, Tel Aviv-Yafo, 61501, Israel

Learn More.

Oppenheimer’s 17th Annual Israeli Conference

Representatives of Sichenzia Ross Ference Kesner LLP and our affiliates, Doron, Tikotzky, Kantor, Gutman, Cederboum and Co., will be attending Oppenheimer’s 17th Annual Israel Conference, to be held at the David Intercontinental Hotel in Tel-Aviv on Sunday, May 21st 2017. Guests will include insurance companies, pension funds, provident funds, mutual funds, banks, venture capitals, and money managers. Based on previous years’ events, this conference is expected to attract approximately 500 participants, more than 40 Israeli companies, as well as considerable media coverage.

May 21st, 2017
Tel-Aviv, Israel

David Intercontinental Hotel
Kaufmann St 12, Tel Aviv-Yafo, 61501, Israel

Learn More

Pioneers 2017 Presented By Joseph Gunnar & Co., LLC

Sichenzia Ross Ference Kesner LLP is a sponsor of the Pioneers 2017 Conference presented by Joseph Gunnar & Co., LLC, to be held at the Mandarin Oriental in New York, NY on May 2nd, 2017. The conference will feature company presentations, one-on-one investor meetings and networking opportunities, with a focus on defense, tech and healthcare companies. Many members of Sichenzia Ross Ference Kesner LLP will be attending this event.

May 2nd, 2017
New York, NY

Mandarin Oriental
80 Columbus Circle,
New York, NY 10023

Learn More.

1 2 3 9